Principal Financial Group Inc Tandem Diabetes Care Inc Transaction History

Principal Financial Group Inc

  • $167 Billion
  • Q1 2025

A detailed history of Principal Financial Group Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 399,450 shares of TNDM stock, worth $8.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
399,450
Previous 388,347 2.86%
Holding current value
$8.08 Million
Previous $14 Million 45.29%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
BUY
$17.89 - $37.53 $198,632 - $416,695
11,103 Added 2.86%
399,450 $7.65 Million
Q4 2024

Jan 31, 2025
BUY
$27.34 - $41.78 $10.6 Million - $16.2 Million
388,347 New
388,347 $14 Million
Q3 2024

Oct 31, 2024
SELL
$35.21 - $47.3 $2.74 Million - $3.68 Million
-77,771 Reduced 17.36%
370,322 $15.7 Million
Q2 2024

Jul 29, 2024
BUY
$30.43 - $53.43 $2.79 Million - $4.9 Million
91,700 Added 25.73%
448,093 $18.1 Million
Q1 2024

Apr 29, 2024
BUY
$22.09 - $35.41 $266,051 - $426,478
12,044 Added 3.5%
356,393 $12.6 Million
Q4 2023

Feb 07, 2024
SELL
$14.28 - $31.03 $154,266 - $335,217
-10,803 Reduced 3.04%
344,349 $10.2 Million
Q3 2023

Nov 02, 2023
SELL
$19.33 - $36.22 $362,418 - $679,088
-18,749 Reduced 5.01%
355,152 $7.38 Million
Q2 2023

Aug 07, 2023
SELL
$24.18 - $42.46 $331,556 - $582,211
-13,712 Reduced 3.54%
373,901 $9.18 Million
Q1 2023

May 09, 2023
BUY
$35.86 - $46.5 $4.79 Million - $6.21 Million
133,479 Added 52.52%
387,613 $15.7 Million
Q4 2022

Feb 09, 2023
BUY
$35.49 - $56.15 $123,256 - $195,008
3,473 Added 1.39%
254,134 $11.4 Million
Q3 2022

Nov 09, 2022
SELL
$43.76 - $68.97 $139,944 - $220,566
-3,198 Reduced 1.26%
250,661 $12 Million
Q2 2022

Aug 10, 2022
BUY
$53.22 - $123.09 $237,999 - $550,458
4,472 Added 1.79%
253,859 $15 Million
Q1 2022

May 09, 2022
SELL
$101.89 - $150.09 $1.84 Million - $2.71 Million
-18,029 Reduced 6.74%
249,387 $29 Million
Q4 2021

Feb 09, 2022
BUY
$118.18 - $153.21 $4.21 Million - $5.45 Million
35,586 Added 15.35%
267,416 $40.3 Million
Q3 2021

Nov 09, 2021
BUY
$93.51 - $129.4 $19.7 Million - $27.3 Million
210,623 Added 993.18%
231,830 $27.7 Million
Q2 2021

Aug 10, 2021
BUY
$77.0 - $100.19 $87,241 - $113,515
1,133 Added 5.64%
21,207 $2.07 Million
Q1 2021

May 10, 2021
SELL
$81.28 - $104.34 $327,639 - $420,594
-4,031 Reduced 16.72%
20,074 $1.77 Million
Q4 2020

Feb 08, 2021
SELL
$86.4 - $121.75 $160,012 - $225,481
-1,852 Reduced 7.13%
24,105 $2.31 Million
Q3 2020

Nov 06, 2020
SELL
$95.43 - $116.09 $168,243 - $204,666
-1,763 Reduced 6.36%
25,957 $2.95 Million
Q2 2020

Aug 05, 2020
BUY
$60.05 - $98.92 $359,699 - $592,530
5,990 Added 27.57%
27,720 $2.74 Million
Q1 2020

May 12, 2020
BUY
$47.37 - $90.04 $1,894 - $3,601
40 Added 0.18%
21,730 $1.4 Million
Q4 2019

Feb 05, 2020
SELL
$53.13 - $71.19 $2.22 Million - $2.98 Million
-41,856 Reduced 65.87%
21,690 $1.29 Million
Q3 2019

Nov 13, 2019
BUY
$57.11 - $73.3 $237,748 - $305,147
4,163 Added 7.01%
63,546 $3.75 Million
Q2 2019

Aug 12, 2019
SELL
$54.41 - $71.7 $1.43 Million - $1.89 Million
-26,331 Reduced 30.72%
59,383 $3.83 Million
Q1 2019

May 10, 2019
BUY
$32.25 - $73.56 $243,165 - $554,642
7,540 Added 9.65%
85,714 $5.44 Million
Q4 2018

Feb 14, 2019
BUY
$28.45 - $40.65 $2.04 Million - $2.92 Million
71,724 Added 1112.0%
78,174 $2.97 Million
Q3 2018

Nov 14, 2018
BUY
$21.39 - $51.17 $137,965 - $330,046
6,450 New
6,450 $276,000

Others Institutions Holding TNDM

# of Institutions
296
Shares Held
72.2M
Call Options Held
3.12M
Put Options Held
159K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.3B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email